food and drug administration

FDA advisory panel rejects widespread Pfizer vaccine booster shots

By Matthew Perrone, Lauren Neergaard, Associated Press

An influential federal advisory panel has overwhelmingly rejected a plan to give Pfizer booster shots against COVID-19 to most Americans, but it approved the extra doses for those who are 65 or older or run a high risk of severe…

WATCH: FDA panel shows frustration in booster dose debate

By Lauran Neergaard, Matthew Perrone, Associated Press, Associated Press

An influential federal advisory panel has overwhelmingly rejected a plan to give Pfizer booster shots against COVID-19 to most Americans, but it endorsed the extra shots for those who are 65 or older or run a high risk of severe…

FDA experts among group opposing U.S. booster shot plan

By Lauran Neergaard, Matthew Perrone, Associated Press

An international group of scientists is arguing the average person doesn't need a COVID-19 booster yet — an opinion that highlights the intense scientific divide over the question.

AP report: FDA official hopeful younger kids can get shots this year

By Lauren Neergaard, Associated Press

Dr. Peter Marks tells The Associated Press he is "very, very hopeful" that vaccinations for 5- to 11-year-olds will be underway by year's end. One company, Pfizer, is expected to turn over its study results by the end of September.

FDA delays decision on e-cigarette ban for vaping giant Juul

By Matthew Perrone, Associated Press

Parents, politicians and anti-tobacco advocates have pressured the FDA for years to ban Juul's high-nicotine devices, which many blame for the recent spike in underage vaping.

FDA allows automatic ‘generic’ swap for brand-name insulin

By Linda A. Johnson, Associated Press

Wednesday's move by the Food and Drug Administration will allow pharmacists to automatically substitute the cheaper version, just as they do with generic pills for other kinds of drugs.

FDA head calls for probe into Alzheimer’s drug review

By Matthew Perrone, Associated Press

Dr. Janet Woodcock announced the extraordinary step via Twitter. It's the latest fallout over last month's approval of Aduhelm, an expensive and unproven therapy that the agency OK'd against the advice of its own outside experts.

Pfizer to seek approval for 3rd vaccine dose, says it could ward off delta variant

By Lauran Neergaard, Associated Press

The company said Thursday that another shot could dramatically boost immunity and maybe help ward off the latest worrisome coronavirus mutant.

FDA trims use of contentious Alzheimer’s drug amid backlash

By Matthew Perrone, Associated Press

The Food and Drug Administration has approved new prescribing instructions that are likely to limit use of a controversial new Alzheimer's drug.

U.S. to resume Johnson & Johnson COVID-19 vaccinations despite rare clot risk

By Lauran Neergaard, Mike Stobbe, Associated Press

Advisers to the Centers for Disease Control and Prevention said Friday the benefits of the single-dose COVID-19 shot outweigh a rare risk of blood clots.